Risk of anaphylaxis after COVID-19 vaccination in South Korea: A nationwide self-controlled case series analysis

Allergy. 2024 Mar;79(3):754-757. doi: 10.1111/all.15975. Epub 2023 Dec 12.

Dongwon Yoon^{1

2}, Ju Hwan Kim^{1

2}, Han Eol Jeong^{1

2}, Hwa Yeon Ko¹, Sung-Ryeol Kim³, Ju-Young Shin^{1

2

4}; CoVaSC Investigators

¹ School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
² Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, South Korea.
³ Division of Pulmonology, Allergy and Critical Care Medicine, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea.
⁴ Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, South Korea.

No abstract available

Publication types